View Full List
Dow Jones Industrial Average
Standard & Poors 500
New York Composite
Updated: 12:31 PM EDT, Mar 11, 2019
Add to My Watchlist
Stories about Bohai Pharmaceutical
The Week in Review: FDA to Step Up Inspections of Foreign Drugmakers
August 13, 2011
The US plans to raise $299 million in fees to fund greatly increased FDA inspections of foreign drugmakers; China’s NDRC ordered price cuts on 82 different drugs, most of them from foreign pharmas;...
Bohai Pharma Acquires Yantai Tianzheng Pharma, a TCM Maker
August 10, 2011
Bohai Pharmaceuticals paid $35 million to acquire Yantai Tianzheng Pharmaceutical Co. Both companies produce and distribute modernized TCM products, and both are headquartered in Yantai City. Not only...
The Week in Review: Sinopharm's M&A Extends Drug Distribution Network
January 28, 2011
Sinopharm Group will pay $198 million for a 60% stake in Hubei drug distributor Le Ren Tang; Kelun Pharma will acquire 80% ownership of Guilin Dahua Pharma, an API company, for $21.9 million; Golden...
Bohai Pharma Announces $1.9 Million Financing
January 24, 2011
Bohai Pharmaceuticals Group raised $1.87 million by placing 748,382 unregistered shares of common stock at $2.50 per share, a 23% premium to the previous closing price. Apparently, no M&A activity is...
The Week in Review: East/West Biopharma Alliances
September 18, 2010
Johnson & Johnson is using “external innovation” in China to discover new drugs; Merck and BGI (formerly the Beijing Genomics Institute) will establish a long-term collaboration; Novo Nordisk plans to...
Bohai Pharma Announces New Products
September 16, 2010
Bohai Pharmaceuticals Group, a TCM pharmaceutical company, said it has added five marketed products to its portfolio so far this year, bringing its total to ten. Bohai holds the rights to produce...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions